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0883-9441/© 2018 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oAvailable online xxxx Background: Systematic reviews of early rehabilitation within intensive care units have highlighted the need for
robust multi-centre randomised controlled trials with longer term follow up. This trial aims to explore the feasi-
bility of earlier and enhanced rehabilitation for patientsmechanically ventilated for ≥5 days and to assess the im-
pact on possible long term outcome measures for use in a deﬁnitive trial.
Methods: Patients admitted to a large UK based intensive care unit and invasively ventilated for ≥5 days were
randomised to the rehabilitation intervention or standard care on a 1:1 basis, stratiﬁed by age and SOFA score.
The rehabilitation intervention involved a structured programme, with progression along a functionally based
mobility protocol according to set safety criteria.
Results: 103 out of 128 eligible patients were recruited into the trial, achieving an initial recruitment rate of 80%.
Patients in the intervention arm mobilized signiﬁcantly earlier (8 days vs 10 days, p = 0.035), at a more acute
phase of illness (SOFA 6 vs 4, p b 0.05) and reached a higher level ofmobility at the point of critical care discharge
(MMS 7 vs 5, p b 0.01).
Conclusion:Wehave demonstrated the feasibility of introducing a structured programme of rehabilitation for pa-
tients admitted to critical care.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Rehabilitation
Critical care
Physiotherapy
Exercise
ICU1. Introduction
Approximately 270,000 patients are admitted annually to general
critical care units in England, with around a third of this requiring me-
chanical ventilation [1]. A strong correlation between muscular weak-
ness and prolonged mechanical ventilation has been observed, with
survivors experiencing signiﬁcant physical, cognitive andmental health
impairments. Themuscle weakness experienced by ICU patients is mul-
tifactorial, with sarcopenia from pre-morbid conditions, disuse atrophy
from bed rest [2] and ICU acquired weakness (ICUAW) all contributing
factors [3]. Muscle wasting occurs early and rapidly during the ﬁrst
week of critical illness, correlates with the degree of organ failure [4],
and is associatedwith failure to wean from the ventilator and increased
in-hospitalmortality [5,6]. Preventing the physical consequences of crit-
ical illness and supporting recovery from intensive care has therefore
been identiﬁed as a high priority area for critical care research [7].Williams).
. This is an open access article underEarly and progressive mobilisation has been demonstrated to be
both safe and feasible for patients admitted to critical care [8].When im-
plemented, programmes of early mobility have demonstrated improve-
ments in physical function and mobility levels, alongside signiﬁcant
reductions in both ICU and hospital length of stay, ventilation days
and a reduction in both the incidence and duration of delirium [9-12].
Despite this, point prevalence surveys have shown rehabilitation levels
within critical care to remain low, particularly for patients still requiring
mechanical ventilation andwith ongoing organ dysfunction [13,14]. Re-
cently published randomised controlled trials of early rehabilitation
within the ICU have failed to show long term signiﬁcant beneﬁts, but
they have been limited by recruiting patients with short lengths of
stay in the ICU and therefore lower levels of ICUAW, or mismatches in
the baseline characteristics [15-18].
An important consideration when interpreting the results of such
trials remains the use of the term “early”, which in itself has yet to bede-
ﬁned and onset of interventions varying by asmuch as 1 week [19]. The
patientsmost at risk of prolonged sequelae are often still too acutely un-
well for activemobilisation to be commenced safely in theﬁrst few days
of critical illness. For these patients the important factor may instead bethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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can be initiated at a more acute stage of the patient's illness than
would otherwise occur rather than simply focussing on a one
size ﬁts all approach. After 10 days in the ICU, the admission diagnosis
and physiological derangement become less important than simple
antecedent patient characteristics such as age, sex and chronic health
status in determining outcome and although only representing
5% of all ICU admissions, these patients with “persistent critical
illness” consume signiﬁcant resource and require dedicated future re-
search [20]. Older ICU survivors in particular suffer prolonged and per-
sistent decline in cognitive and physical function with those with a
length of stay N2 weeks at highest risk for 1-year mortality and
disability [21].
Our group has previously published the results of a quality improve-
ment project, where a new supportive rehabilitation team was created
with a focus on promoting early and enhanced rehabilitation for pa-
tients at high risk of prolonged ICU andhospital stays [11]. The introduc-
tion of the team led to a signiﬁcant improvement in mobility at ICU
discharge, and this was associated with a signiﬁcant reduction in ICU
length of stay (LOS), ventilator days and in-hospitalmortality. However,
only a minority of the eligible ICU patients was treated by the team and
unmeasured confounding factorsmay have impacted on results seen. In
a before and after design, it was difﬁcult to deﬁne on an individual pa-
tient level the constituent parts of standard and enhanced care. The re-
habilitation intervention therefore required further evaluation prior to a
multicentre trial.
The aimof this trialwas to explore the feasibility of delivery of earlier
and enhanced rehabilitation for patients mechanically ventilated for
≥5 days and to assess the impact on possible long term outcome mea-
sures for use in a future deﬁnitive trial. Speciﬁcally, the objectives
were to:
• Estimate rates of recruitment and consent from eligible patients and
to describe the baseline characteristics of the participants in terms of
co-morbidities, physical function and illness severity.
• Test the rehabilitation intervention in terms of compliance, differenti-
ation from standard care and ability to increase mobility levels at ICU
discharge.
• Estimate retention of participants and response rates to follow-up
questionnaires.
• Evaluate a range of clinical and patient-reported outcome measures
to aid selection of the most appropriate primary outcome measure
for a deﬁnitive trial, with estimates of variance for sample size
calculation.
2. Material and methods
The protocol for this trial has been previously published in full [22].
Ethical approval was obtained from the Research Ethics Committee East
Midlands –Nottingham1 (reference15/EM/0114) on the 8th April 2015
and trial was registered with ISRCTN registry (ISRCTN90103222). Writ-
ten informed consent was obtained from all participants, a personal
consultee or a Registered Medical Practitioner. The conduct and
reporting of the trial conforms to CONSORT extension guidelines [23].
This research did not receive any speciﬁc grant from funding agencies
in the public, commercial, or not-for-proﬁt sectors.3. Design
We conducted a single centre, 1:1 randomised controlled feasibility
trial of earlier and enhanced rehabilitation for patients admitted to crit-
ical care. There was no a priori calculation of sample size, with a target
recruitment of 100 patients speciﬁed to allow adequate assessment of
outcome measures.4. Participants
Patients admitted to the critical care unit of a large tertiary referral
university teaching hospital were recruited between June 2016 and
September 2017. Inclusion criteria were adults (≥16 years of age) who
had been invasively ventilated for at least 4 days and expected to con-
tinue for at least 24 h. Patients were not eligible for the trial if they
had a profound neurological deﬁcit (deﬁned as unlikely to return to a
Glasgow Coma Score of at least 14), an orthopaedic injury with contra-
indications to mobilise (e.g. pelvic fracture), were unable to mobilise at
least 10 m prior to admission (with or without an aid), had pre-existing
neuromuscular disease, had been invasively ventilated at another facil-
ity for N48 h prior to admission or in hospital for N7 days prior to the
onset of mechanical ventilation. Patients were also excluded if with-
drawal of treatment was expected within 24 h of potential recruitment.
5. Randomisation and blinding
Participants were randomised on a 1:1 basis to enhanced rehabilita-
tion or standard care using a computer based stratiﬁed blocked
randomisation, stratiﬁed for age (b50 years vs ≥50 years) and SOFA
score on the day of recruitment (b9 versus ≥9). Recruitment and com-
pletion of assessments was undertaken by the research nursing team
whowere independent from the therapy teamdelivering rehabilitation.
Given the nature of the intervention, it was not possible to blind physio-
therapists or participants to group allocation.
6. Study interventions
6.1. Standard care
All patients within our institution are assessed by the physiotherapy
team within 24 h of admission to critical care to obtain background in-
formation on reason for admission, as well as any pre-existing condi-
tions that may be relevant. They then continue to be seen on a daily
basis on weekdays, with rehabilitation commencing based on the indi-
vidual physiotherapists own clinical reasoning. Physiotherapy provision
is funded at a ratio of 1 physiotherapist to 10 patients, with an average
treatment time of 30–45min per patient per dayMonday to Fridaywith
one physiotherapist.When discharged to theward environment, a tele-
phone handover is provided to the receiving therapist who then con-
tinues the rehabilitation until the patient is deemed safe for discharge,
with no further input provided by the critical care team.
6.2. Enhanced rehabilitation (intervention group)
Physiotherapy sessions for subjects assigned to the intervention
groupwere delivered bymembers of a specialist critical care rehabilita-
tion teamwhowere separate to the normal physiotherapy team, aiming
tominimise contamination between groups. Following recruitment and
randomisation subjects in the intervention groupwere assigned a phys-
iotherapy key worker who completed a standardized comprehensive
assessment. This was used to gain additional background information
regarding pre-existing physical function, any psychological history and
pre admission exercise capacity. Following this assessment an individu-
ally tailored rehabilitation programmewas devised, with the rehabilita-
tion plan displayed in the subjects' bed space to aid communication and
track daily achievements.Weekly goal settingmeetingswere held to re-
view progress and update treatment plans as required. To facilitate on-
going rehabilitation following critical care discharge both verbal and
written handovers were provided to ward therapy staff. For patients
achieving a Manchester Mobility Score (MMS) of ≤4 at critical care dis-
charge (unable to stand independently), ongoing rehabilitation was
provided by the key worker in conjunction with the ward therapists
for the ﬁrst week following discharge from critical care. This aimed
to ensure a seamless handover of care and maximise ongoing
409D. McWilliams et al. / Journal of Critical Care 44 (2018) 407–412rehabilitation. More detailed information regarding the rehabilitation
pathway is available from our previously published protocol [22].
6.3. Both groups
All medical care provided was at the discretion of the responsible
intensivist. Rehabilitation interventions by all members of the clinical
team at each stage of the patient pathway were carefully recorded by
the research team, with reasons for any missed rehabilitation sessions
documented. In accordance with current unit practice, all patients
with a length of stay over 14 days were discussed at weekly multidisci-
plinary team meetings attended by consultant medical staff, physio-
therapists, senior nursing staff, speech and language therapists
and occupational therapists, with collaborative treatment goals set,
reviewed and updated.
7. Outcome measures
The objective of this study was to evaluate the feasibility of the en-
hanced rehabilitation intervention in terms of recruitment process,
compliance and differentiation from standard care, and to provide
pilot data as to outcome measures and variance for a phase III trial. For
the recruitment process, this was assessed as the proportion of eligible
patients who were recruited and completed all study assessments.
Compliance and differentiation of groups was assessed by the time to
ﬁrst mobilisation deﬁned as Manchester Mobility Score (MMS) of ≥2
(sitting on the edge of the bed or higher), dose of physiotherapy in
terms of therapy time, recording of reasons for missed sessions, the
daily maximum MMS achieved, and mobility level at ICU discharge.
As this was a feasibility trial numerous additional outcomes were
collected to assess any potential impact of the intervention on other
key areas. These included hospital based outcomes such as ICU and hos-
pital length of stay and mortality, as well as measures of physical func-
tion (Barthel Index) strength (MRC sum score and grip dynamometry)
and health related quality of life (SF36 v2). Completion of Barthel and
SF-36 scores at 3 and 12 month assessments were via telephone inter-
view, with a follow up sent by post if no response was received.
8. Statistical analysis
Ordinal and continuous variables were compared between arms
using Mann-Whitney tests. Data were summarised as either medians
with interquartile ranges (IQRs), or as theproportions of patientswithin
various intervals for ordinal variables with small ranges. Nominal vari-
ables were compared between arms using Fisher's exact tests. All anal-
yses were performed using IBM SPSS 22 (IBM Corp. Armonk, NY). Cases
with missing data were excluded on a per-analysis basis, and p b 0.05
was deemed to be indicative of statistical signiﬁcance throughout.
9. Results
A total of 103 out of 128 eligible patients were recruited into the
trial, achieving an initial recruitment rate of 80%. One patient withdrew
from the study, and did not allow their data to be used, and so was ex-
cluded from the analysis. This left 50 patients in the standard treatment
arm, and 52 patients in the enhanced treatment arm (see Fig. 1). For the
cohort as a whole, the median age was 62 years (IQR: 47–70), and the
majority of patients weremale (61%). Table 1 compares a range of base-
line and demographic factors between the two study arms, with no sig-
niﬁcant differences detected between the groups. Approximately half of
patients allocated to each group had at least one comorbidity measured
using the Charlson co morbidity index.
Median time to ﬁrst mobilisation was signiﬁcantly shorter in the in-
tervention group (8 days vs 10 days, p = 0.035), with a higher SOFA
score at 1st mobilisation (6 vs 4, p = 0.0278) and a higher level of mo-
bility achieved at ITU discharge (MMS 7 vs 5, p = 0.016). No signiﬁcantdifference was observed regarding average daily duration of therapy,
although subjects in the intervention arm received a higher proportion
of ‘active’ rehabilitation sessions (deﬁned as achieving anMMS ≥ 2 dur-
ing the session) and were more likely to walk N30 m at the point of
critical care discharge (73% vs 47%, p = 0.006). There were also signiﬁ-
cantly more ‘missed’ therapy sessions in the control group (16% vs 10%,
p b 0.001), the reasons for which are given in Table 2. Patients in the in-
tervention group were more likely to have an individualised treatment
plan formulated including goals for rehabilitation setwithin critical care
(100% vs 62%, p b 0.0001) and updated weekly throughout the ICU stay
(100% vs 16%, p b 0.0001). Aswith previous studies in this area, early ac-
tivity was safe and feasible within critical care. There were 27 recorded
SAE's during the study period, although none of these were attributable
to the intervention.
There was no evidence of signiﬁcant differences between the
groups for any of the in-hospital outcomes, components of length of
stay, or mortality (see Tables 3 and 4). The median mental component
summary score (MCS) of the SF36 was found to be similar in the
two arms when measured at baseline (enhanced vs. standard: 40 vs.
44, p= 0.582), ITU discharge (33 vs. 39, p= 0.499) and at hospital dis-
charge (36 vs. 41, p = 0.346). However, by three months post-
discharge, the score was found to be signiﬁcantly higher in the en-
hanced arm, with a median of 57, compared to 51 in the standard treat-
ment arm (p = 0.042).
9.1. Missing data
Some of the factors considered had a large quantity of missing
data, with data unavailable in over 50% of the cohort in some cases
(e.g. anxiety/depression scores). For the factors relating to ICU/Hospital
discharge, this was largely due to nurses not having the opportunity to
collect the necessary data before the patient was discharged, hence it is
reasonable to assume that these data are missing at random. However,
for data collected on admission, some instances of missing data reﬂect
cases where the patient was too unwell to complete the assessment,
hence excluding these cases may have introduced bias.
The rates ofmissing data for each factorwere comparedbetween the
two arms, with the results reported in Supplementary Table 1. This
found no signiﬁcant differences in the rates of missing data between
arms for any of the factors included in the analysis. Hence, if any selec-
tion bias were present, the prevalence appears to be similar in the two
arms, which should have largely negated the effect of this on the com-
parisons between arms.
10. Discussion
More patients are surviving critical illness, and strategies to address
the long term physical and psychological sequelae of critical illness are
urgently needed. In this single centre trial, we assessed the feasibility
of introducing a programme of earlier and enhanced rehabilitation for
patients admitted to critical care and mechanically ventilated for
≥5 days. This population was speciﬁcally chosen to target patients
most at risk of ICU acquired weakness, aiming to ﬁnd the balance be-
tween excluding those with short stays and expected faster trajectories
of recovery, whilst still ensuring rehabilitation could be commenced
early enough to be effective.
Our results demonstrate that recruiting to a trial was feasible, with
103/128 (80%) of eligible patients randomised. Patients in the interven-
tion arm were actively mobilized earlier (8 vs 10 days; p = 0.035) and
the higher SOFA scores at ﬁrst mobilisation suggest this was taking
place at a more acute phase of the patients illness. The intervention
group also achieved a higher level of mobility within critical care
(MMS 7 vs 5, p = 0.016), with 73% able to walk at the point of ITU dis-
charge. Of note, this trial was performed in a critical care unit that had
already successfully implemented a quality improvement initiative in
earlier mobilisation [11]. The mobility levels achieved at ICU discharge
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Fig. 1. CONSORT participant ﬂow diagram for primary endpoints.
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post implementation of the QI project (MMS 5 = the ability to step
transfer with assistance). Thus, the improvements seen are in addition
to previous beneﬁts, and not attributable to a “return to baseline” fol-
lowing the end of the QI initiative.
It is useful to compare ourﬁndings with those of the other published
trials. As stated previously, a QI project had been completed for earlier
rehabilitation within our ICU and as such may have represented a pop-
ulation receiving a higher level of rehabilitation than other similar units.
Average daily duration of physiotherapy was 35.4 min in the standard
care group, with active rehabilitation occurring in 51% of these sessions
and all but one patient mobilising within the ICU. This demonstrates a
greater intensity of physical rehabilitation than that provided as stan-
dard care in other previous trials [15-18]. The recently published
EPICC trial [15], which aimed to compare a higher intensity of physio-
therapy for patients admitted to critical care, failed to demonstrate im-
provements in either short term outcomes or overall recovery at
3 months. This is a similar ﬁnding to other recent trials which have
attempted to increase the dose or frequency of physiotherapy in those
with already established services, which have failed to recreate the pos-
itive outcomes seen in other early rehabilitation trials [17,18].Signiﬁcant differences were seen between groups in the structure of
therapy treatment, with higher levels of goals set and reviewed within
the intervention arm. This was achieved with no signiﬁcant difference
in either the total number of sessions or the average duration of therapy
delivered between groups, although compliance and delivery of active
rehabilitation sessions was higher in the intervention group. Our data
supports the hypothesis that the implementation of early and struc-
tured rehabilitation is about more than just increasing the dose of phys-
iotherapy. The key to implementation is promoting a cultural change
which supports rehabilitation and having a robust structure in place to
ensure ongoing consistency with service delivery [24].
Designed as a feasibility trial, our study was not powered to look at
any speciﬁc long term outcome. A slight reduction was seen between
groups in ventilator days and ICU length of stay which would warrant
further investigation, although no difference was observed for either
total hospital length of stay or mortality. MRC sum scores and grip
strength did not differ between groups at ICU discharge, highlighting
the limitations in relating functional recovery to measures of muscle
strength. Patient reported outcomemeasures of Barthel, Hospital Anxi-
ety and Depression and SF-36 also showed no difference between
groups, except in themental component score of the SF-36 at 3months.
Table 1
Patient demographics.
Standard Enhanced p-Value
N Statistic N Statistic
Age 50 61 (47–70) 52 62 (46–68) 0.656
Gender (% male) 50 31 (62%) 52 31 (60%) 0.841
SOFA 50 10 (6–13) 52 10 (7–14) 0.845
Apache 11 38 17 (14–21) 41 18 (15–22) 0.336
Charlson comorbidity index 50 52 0.965⁎
0 25 (50%) 25 (48%)
1 12 (24%) 15 (29%)
2+ 13 (26%) 12 (23%)
Admission speciality 50 52 0.752
Cardiothoracics 11 (22%) 9 (17%)
Medicine 10 (20%) 16 (31%)
Neurosurgery 7 (14%) 7 (13%)
Surgery 19 (38%) 16 (31%)
Trauma/burns 3 (6%) 4 (8%)
Chronic respiratory disease 50 8 (16%) 52 11 (21%) 0.613
Heart disease 50 11 (22%) 52 9 (17%) 0.622
ES renal failure 50 4 (8%) 52 4 (8%) 1.000
Chronic liver disease 50 7 (14%) 52 5 (10%) 0.551
Data are reported as median (IQR), with p-values from Mann-Whitney tests, or as N
(Column %), with p-values from Fisher's exact tests, unless stated otherwise.
⁎ p-Value from a Mann-Whitney test on the untransformed factor.
Table 3
In-hospital outcomes.
Standard Enhanced p-Value
N Statistic N Statistic
Days on ITU 43 18 (12–28) 45 16 (13−21) 0.339
ICU dependency days 43 17 (10–26) 45 14 (12−21) 0.613
Days vented 43 12 (6–17) 44 10 (7–15) 0.210
Sedation days 43 7 (5–11) 44 8 (5–9) 0.870
Days on ward 42 10 (7–18) 42 12 (6–20) 0.899
Total length of stay (days) 42 29 (20–46) 43 29 (22–41) 0.984
ITU readmission 42 2 (5%) 44 2 (5%) 1.000
Mortality⁎
ICU 50 7 (14%) 52 7 (13%) 1.000
Ward 43 1 (2%) 45 3 (7%) 0.617
Post-discharge (3 months) 42 5 (12%) 42 4 (10%) 1.000
Cumulative mortality 50 13 (26%) 52 14 (27%) 1.000
Data are reported as median (IQR), with p-values from Mann-Whitney tests, or as N
(Column %), with p-values from Fisher's exact tests, unless stated otherwise.
⁎ With the exception of the cumulativemortality rates, the quoted statistics are non-
cumulative, i.e. the ward mortality rate excludes any patients that died in ICU. Cumu-
lative mortality represents the overall mortality rate between admission and three
months post-discharge.
Table 4
Patient outcomes.
Standard Enhanced p-Value
N Statistic N Statistic
Bartel
Pre-admission 38 100 (95–100) 35 100 (85–100) 0.293
ITU discharge 22 55 (35–75) 26 45 (35–80) 0.955
411D. McWilliams et al. / Journal of Critical Care 44 (2018) 407–412The biggest limitation to our study is the lack of blinding and poten-
tial for contamination across groups. Due to the size of our critical care
unit it was possible to ensure patients in the intervention and control
groups were assessed and treated by different physiotherapists. This
was not the case however with medical staff, nurses or other members
of the MDT which may have impacted on the care provided for each
group. Another signiﬁcant limitation is the degree of missing data and
the high loss to follow up rate. This occurred despite the presence of
dedicated research nurses for data collection and was related to a num-
ber of factors. An example of this was the completion of questionnaires
in critical care or on return to the ward, where a number of patients
lacked the cognitive ability at this time point. The missing data limits
the precision of the results and could be a source of bias, although the
rate of non-completion was similar for outcomes between groups. The
loss to follow up for the SF36 questionnaires was also similar to those
seen in other trials assessing critical care survivors following hospital
discharge [15,18].Table 2
Physiotherapy activity.
Control
(n = 43)
Enhanced
(n = 44)
p
Number of completed sessions 560 616
Missed sessions 108 65 b0.001
Patient declined 16 16
Clinical deterioration 17 15
Weekend 36 27
Procedure 7 6
Lack of staff 13 1
Not documented 19 0
Average daily duration (mins) 35.4 38.3 0.1577
Active rehabilitation 284 (51%) 394 (64%) 0.0001
Time to 1st mobilisation (days) 10 (7–12) 8 (7–11) 0.035
SOFA at 1st mobilisation 4 (3–6) 6 (4–8.25) 0.0278
MMS at ICU discharge 5 (4–7) 7 (5–7) 0.016
1–2 5 (12% 3 (7%)
3–5 18 (42%) 9 (20%)
6–7 20 (47%) 32 (73%) 0.006
Goals set at least once in ICU 62% 100% b0.0001
Goals updated weekly 16% 100% b0.0001
Documented treatment plan updated weekly 16% 100% b0.0001
Data are reported as median (IQR), with p-values from Mann-Whitney tests, or as N
(Column %), with p-values from Fisher's exact tests, unless stated otherwise. Active reha-
bilitation is deﬁned as achieving an MMS of ≥ 2 during the session.
Bold p-values are signiﬁcant at p b 0.05.11. Conclusion
We have demonstrated that it is feasible to recruit patients to a trial
of earlier and enhanced rehabilitation and that by improving the struc-
ture of therapy intervention it is possible to reduce the time to ﬁrst
mobilisation and improve the mobility level at ICU discharge. These ef-
fects were seen in a critical unit with an already high level of active re-
habilitation compared to national and international studies. The long
term effect of this improvement in mobility within the ICU warrantsHospital discharge 21 90 (85–95) 17 85 (80–95) 0.334
MRC
ITU discharge 34 53 (48–58) 35 53 (44–58) 0.767
Hospital discharge 34 58 (53–60) 35 58 (54–60) 0.833
Anxiety
ITU discharge 15 8 (6–13) 25 7 (5–14) 0.703
Hospital discharge 18 7 (5–9) 17 5 (3−12) 0.466
Depression
ITU discharge 15 6 (4–14) 25 9 (5–13) 0.466
Hospital discharge 19 7 (4–10) 17 8 (4–11) 0.795
Grip
ITU discharge 33 15.4 (7.4–18.9) 35 13.1 (9.1–17.8) 0.614
Hospital discharge 34 16.7 (12.6–20.7) 35 17.1 (11.8–22.4) 0.818
PCS
Baseline 34 38.5 (27.6–55.0) 36 39.3 (30.3–51.8) 0.829
ITU discharge 18 29.9 (26.3–33.4) 19 29.1 (25.5–36.0) 0.822
Hospital discharge 19 30.5 (26.5–36.3) 17 32.2 (27.3–36.8) 0.552
3 Months 23 37.6 (35.8–47.6) 22 46.1 (35.5–52.3) 0.307
MCS
Baseline 34 44.0 (32.0–54.7) 36 40.2 (28.5–57.8) 0.587
ITU discharge 18 38.7 (27.0–47.4) 19 33.2 (25.9–43.0) 0.499
Hospital discharge 19 41.3 (29.6–51.6) 17 35.8 (25.1–46.2) 0.346
3 Months 23 51.2 (26.4–57.4) 22 57.4 (38.4–60.4) 0.042
Data are reported as median (IQR), with p-values from Mann-Whitney tests, or as N
(Column %), with p-values from Fisher's exact tests, unless stated otherwise.
Bold p-values are signiﬁcant at p b 0.05.
412 D. McWilliams et al. / Journal of Critical Care 44 (2018) 407–412further investigation in a phase III trial, which will need to ensure that
the mobility programme is robustly structured and delivered.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.jcrc.2018.01.001.
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